![[The University of Leicester]](unilogo.gif)
Professor Melanie J Davies
Professor of Diabetes Medicine, University of Leicester and Honorary Consultant, University Hospitals of Leicester
MB ChB, 1985, University of Sheffield
MRCP, 1988
MD, 1994, University of Sheffield
FRCP, 2000
Tel: 0116 258 8357 Email: melanie.davies@uhl-tr.nhs.uk
Address: Department of Cardiovascular Sciences, Diabetes Research, Leicester General Hospital LE5 4PW
For general enquiries, please email Denise Robinson, secretary, or telephone 0116 258 6481
Research interests
-
Screening and Early Detection of Type 2 Diabetes
-
Prevention of Type 2 Diabetes
-
Complex interventions, including structured educational interventions in Type 2 Diabetes Mellitus
New glucose lowering therapies in diabetes -
Novel Cardiovascular Risk Markers and Metabolic Syndrome
External Positions
Expert Advisor to the National Screening Committee, 2006 - current
Member of the Department of Health Vascular Board, 2006 - current
Member of the Department of Health Steering Group on Structured Education of Diabetes in England and Wales, 2004 - current
Member of the Novo-Nordisk Research Foundation Committee, 2003 - current
Member of Diabetes UK Research Committee, 2003 - current
Member of NICE Guideline Development Group for Type 2 Diabetes Mellitus, 2006 - 2008
Member of NICE Guideline Development Group for Type 1 Diabetes Mellitus, 2003 - 2004
NICE Guidelines, Technology Appraisal for the Glitazones. Nominated Expert for Diabetes UK 2003
Member of the MRC/Department of Health Research Review in Diabetes 2002
Diabetes Care and Advisory Committee of Diabetes UK, 1999 - 2003
Specialist Care Committee of Diabetes UK, 1999 - 2003
Editorial Board Member for Continuing Education Section of Diabetic Medicine, 1998 - 2004
Associate Editor for Diabetic Medicine, 1998 - 2004
Key Publications
Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, Dallosso HM, Daly H, Doherty Y, Eaton S, Fox C, Oliver L, Rantell K, Rayman G, Khunti K on behalf of the DESMOND Collaborative. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ 2008;336:491-495
Pratley RE, Nauck M, Bailey T, Montanya E, Cuddihy R, Filetti S, Thomsen AB, Søndergaard RE, Davies M; 1860-LIRA-DPP-4 Study Group. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. Lancet 2010 Apr 375 9724 1447-56
Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK; 4-T Study Group. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med. 2009 Oct 29 361 18 1736-47
Carter P, Gray LJ, Troughton J, Khunti K, Davies MJ. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ. 2010 Aug 18 341 c4229
Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K, Skinner TC, Davies MJ. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ. 2010 Aug 20 341 c4093
Yates T, Davies M, Gorely T, Bull F, Khunti K. Effectiveness of a pragmatic education programme aimed at promoting walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. Diabetes Care 2009;32(8):1404-1410
Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, Davies MJ, Khunti K. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008; 336:1180-1185
Gray LJ, Taub NA, Khunti K, Gardiner E, Hiles S, Webb DR, Srinivasan BT, Davies MJ. The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med. 2010 Aug 27 8 887-95
Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC for the 4-T Study Group. Addition of Biphasic, Prandial or Basal Insulin to Oral Therapy in Type 2 Diabetes. N Engl J Med 2007;357(17):1716-1730
Webb DR, Khunti K, Silverman R, Gray LJ, Srinivasan B, Lacy PS, Williams B, Davies MJ. Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetologia. 2010 Jun 53 6 1190-8
